Workshop: HALOを用いたMASHモデルマウスの定量的病理組織解析とその有用性
We invite you to our workshop at the 24th annual meeting of the Japanese Society of Digital Pathology, presented by Dr. Kiyokazu Ozaki.
Workshop: HALOを用いたMASHモデルマウスの定量的病理組織解析とその有用性 Read More »
News
Open Science Does Not Require Open Source: The Role of Open Pathology in Research
The importance of open science continues to grow as digital pathology workflows become increasingly sophisticated and integrated.
Open Science Does Not Require Open Source: The Role of Open Pathology in Research Read More »
Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development
Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the HALO® ADC Target Scoring module, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis.
HALO® ADC Target Scoring Module Features and Functionalities
We’re excited to announce the launch of our new ADC Target Scoring module, designed to support continuous quantitative measurement of target protein expression across different cellular compartments.
HALO® ADC Target Scoring Module Features and Functionalities Read More »
Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis
Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), and areas of benign tissue prior to biomarker analysis. This zero-click preprocessing and tissue classification workflow represents a critical step in ensuring accurate and reproducible AI outputs.
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI Read More »
HALO®, HALO AI, and HALO Link 4.3 Features and Functionalities
In this blog post, you can learn about the new features coming in version 4.3 of HALO®, HALO AI, and HALO Link, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
HALO®, HALO AI, and HALO Link 4.3 Features and Functionalities Read More »
New! ADC Target Scoring Module
Streamline analysis for antibody-drug conjugate (ADC)-focused assays and perform quantitative continuous scoring and spatial analysis.
New! ADC Target Scoring Module Read More »
HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration Read More »
HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability
Albuquerque, NM, July 14, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency.